Cerebral Vein Thrombosis Clinical Trial
Official title:
A Registry Study of Cerebral Venous Sinus Thrombosis in China
This study will investigate the epidemiology, risk factors, diagnostics, treatment, and the long-term prognosis of cerebral venous thrombosis in China.
The epidemiology, risk factors, diagnosis and treatment of Cerebral Venous Thrombosis (CVT) in China are still unclear. A retrospective hospital-based study will be conducted at fifty different hospitals across 31 provinces in China. This study will use ICD-10 to search patients diagnosed with CVT between January 1, 2018 and June 15, 2022 across 31 provinces and municipalities of 104 hospitals in China. Risk factors, clinical and radiological findings, treatment and short-term outcomes will be recorded from the hospital record system. Finally, a prospective follow-up will be conducted for all of the patients enrolled above. By combining data collected from retrospective hospital records with the new follow-up, it will be possible to better understand the epidemiology, risk factors, diagnosis, treatment and the long-term prognosis of CVT in China. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT04269954 -
The Efficacy and Safety of Batroxobin Combined With Anticoagulation in Cerebral Venous Sinus Thrombosis
|
Phase 4 | |
| Not yet recruiting |
NCT03919305 -
Cerebral Venous Thrombosis Cohort Study in China Mainland
|
||
| Recruiting |
NCT03273179 -
Cerebral Venous Sinus Thrombosis: Re-exploration of Clinical Assessment Scales
|
N/A | |
| Recruiting |
NCT05291585 -
The Dedicated Venous Sinus Thrombectomy Stent for Endovascular Treatment of Cerebral Venous Sinus Thrombosis.
|
N/A | |
| Recruiting |
NCT04966182 -
Application CT and MRI in Cerebral Venous Sinus Thrombosis
|
||
| Recruiting |
NCT05021198 -
The Norwegian Cerebral Venous Thrombosis Study
|
||
| Withdrawn |
NCT04580238 -
Onabotulinum Toxin A (Botox) for the Treatment of Persistent Post-Stroke and Vascular Headache
|
Phase 1 |